The latest price target for MetLife (NYSE:MET) was reported by TD Cowen on November 27, 2024. The analyst firm set a price target for $99.00 expecting MET to rise to within 12 months (a possible 25.65% upside). 30 analyst firms have reported ratings in the last year.

The latest analyst rating for MetLife (NYSE:MET) was provided by TD Cowen, and MetLife maintained their buy rating.

The last upgrade for MetLife Inc happened on January 8, 2024 when Goldman Sachs raised their price target to $80. Goldman Sachs previously had a neutral for MetLife Inc.

The last downgrade for MetLife Inc happened on January 9, 2023 when Goldman Sachs changed their price target from $80 to $78 for MetLife Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MetLife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MetLife was filed on November 27, 2024 so you should expect the next rating to be made available sometime around November 27, 2025.

While ratings are subjective and will change, the latest MetLife (MET) rating was a maintained with a price target of $97.00 to $99.00. The current price MetLife (MET) is trading at is $78.79, which is out of the analyst’s predicted range.